Pleco Therapeutics BV jobs and careers
About Pleco Therapeutics BV
Pleco Therapeutics' aim is to establish the market value and therapeutic potential of our patented PlecoidTM medications by focusing first on orphan cancer treatments. Current pre-clinical development activities at the firm are focused on the development of medicines for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, andSmall-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer. Both diseases carry a poor prognosis.
Founded in 2018 by Dan Gelvan, Gerben de Rijk, Ivo Timmermans and Rudi Jansen.
- Founded
- 2018
- Employees
- 1 to 10
- Total funding
- $17.3M
Leadership
The top of Pleco Therapeutics BV's org chart, with how many people report into each leader.
Ivo Timmermans
Chief Executive Officer
3 reports
Dan Gelvan
Chief R&D Officer and co-founder
Julie Powell
Marketing and Communications Director
Gerben de Rijk
Chief Legal Officer
Jobs at Pleco Therapeutics BV
No open positions right now. Explore more companies on TheJobsMap.